{"id":246086,"date":"2021-11-22T16:48:50","date_gmt":"2021-11-22T21:48:50","guid":{"rendered":"https:\/\/oncubanews.com\/en\/?p=246086"},"modified":"2021-11-22T16:48:50","modified_gmt":"2021-11-22T21:48:50","slug":"cuba-clinical-trial-for-booster-dose-with-mambisa-vaccine-candidate-approved","status":"publish","type":"post","link":"https:\/\/oncubanews.com\/en\/cuba\/cuba-clinical-trial-for-booster-dose-with-mambisa-vaccine-candidate-approved\/","title":{"rendered":"Cuba: clinical trial for booster dose with Mambisa vaccine candidate approved"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Cuba\u2019s Center for State Control of Medicines, Equipment and Medical Devices (CECMED) approved the start of a clinical trial of a <\/span><a href=\"https:\/\/oncubanews.com\/en\/coronavirus\/\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">COVID-19<\/span><\/a><span style=\"font-weight: 400;\"> booster shot with the Mambisa vaccine candidate.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">This was confirmed on the Twitter account of the Center for Genetic Engineering and Biotechnology (CIGB), the entity that developed the drug, which specified that \u201csubjects previously vaccinated\u201d against the infectious disease will participate in the study where the immunogen\u2019s \u201ceffect and safety will be evaluated.\u201d<\/span><\/p>\n<blockquote class=\"twitter-tweet\" data-width=\"500\" data-dnt=\"true\">\n<p lang=\"es\" dir=\"ltr\">Aprob\u00f3 el CECMED el inicio del estudio cl\u00ednico de una <a href=\"https:\/\/twitter.com\/hashtag\/DosisDeRefuerzo?src=hash&amp;ref_src=twsrc%5Etfw\">#DosisDeRefuerzo<\/a> con el candidato vacunal <a href=\"https:\/\/twitter.com\/hashtag\/Mambisa?src=hash&amp;ref_src=twsrc%5Etfw\">#Mambisa<\/a> contra la COVID-19 en sujetos previamente vacunados, donde se evaluar\u00e1 su efecto y la seguridad. <a href=\"https:\/\/twitter.com\/CIGBCuba?ref_src=twsrc%5Etfw\">@CIGBCuba<\/a> <br \/> <a href=\"https:\/\/twitter.com\/hashtag\/SiemprePorLaVida?src=hash&amp;ref_src=twsrc%5Etfw\">#SiemprePorLaVida<\/a> <a href=\"https:\/\/t.co\/PWV1KSR40Y\">pic.twitter.com\/PWV1KSR40Y<\/a><\/p>\n<p>&mdash; CIGBCuba (@CIGBCuba) <a href=\"https:\/\/twitter.com\/CIGBCuba\/status\/1462092428442230794?ref_src=twsrc%5Etfw\">November 20, 2021<\/a><\/p><\/blockquote>\n<p><script async src=\"https:\/\/platform.twitter.com\/widgets.js\" charset=\"utf-8\"><\/script><\/p>\n<p><span style=\"font-weight: 400;\">The Mambisa vaccine candidate, one of the five created on the island against COVID-19, has as a novelty that it can be applied \u201cby means of a nasal spray, a drop dispenser or by means of a Cuban device with a syringe.\u201d It is \u201ca unique formulation of this type based on the platform of recombinant-produced antigens, a technology with high security,\u201d according to <\/span><a href=\"https:\/\/www.prensa-latina.cu\/2021\/11\/20\/aprueban-en-cuba-estudio-con-candidato-anticovid-19-mambisa\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">official information cited <\/span><\/a><span style=\"font-weight: 400;\">by Prensa Latina (PL).<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The press agency also reported that this drug \u201cis being evaluated together with the Abdala vaccine, also from the CIGB, in a phase II clinical trial since November 3 for patients convalescing from COVID-19 that is being carried out at the Hermanos Ameijeiras Clinical Surgical Hospital\u201d in Havana, which included people allergic to thimerosal.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u201cA total of 120 volunteers from the same group were summoned last July in phase I of the clinical trial for convalescents with the same drugs,\u201d said PL.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">For its part, the Agencia Cubana de Noticias (ACN) news agency <\/span><a href=\"http:\/\/www.acn.cu\/salud\/87459-autoriza-cecmed-estudio-clinico-de-candidato-vacunal-mambisa-como-dosis-de-refuerzo\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">recalled<\/span><\/a><span style=\"font-weight: 400;\"> that \u201crecently the CECMED issued a positive opinion in favor of the booster dose with the Cuban Soberana 02 and Abdala COVID-19 vaccines.\u201d<\/span><\/p>\n<blockquote class=\"wp-embedded-content\" data-secret=\"2KxKRXyj6Q\"><p><a href=\"https:\/\/oncubanews.com\/en\/coronavirus\/cuba-to-apply-booster-doses-of-its-covid-19-vaccines\/\">Cuba to apply booster doses of its COVID-19 vaccines<\/a><\/p><\/blockquote>\n<p><iframe loading=\"lazy\" class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; clip: rect(1px, 1px, 1px, 1px);\" title=\"&#8220;Cuba to apply booster doses of its COVID-19 vaccines&#8221; &#8212; OnCubaNews English\" src=\"https:\/\/oncubanews.com\/en\/coronavirus\/cuba-to-apply-booster-doses-of-its-covid-19-vaccines\/embed\/#?secret=sV9ykfg5tw#?secret=2KxKRXyj6Q\" data-secret=\"2KxKRXyj6Q\" width=\"500\" height=\"282\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe><\/p>\n<p><span style=\"font-weight: 400;\">\u201cAt that time, the Regulatory Agency evaluated the reports presented by the Finlay Vaccine Institute (IFV) and the CIGB, which showed the need for the administration of a booster dose six months after completing the approved immunization scheme against COVID-19 in the country,\u201d the ACN added in its report.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Cuba, which currently has more than 80% of its inhabitants fully vaccinated against the disease, has already begun to apply booster doses to health workers and other risk groups, as part of a strategy that will later be extended to the rest of the population.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>This was confirmed on the Twitter account of the Center for Genetic Engineering and Biotechnology (CIGB), the entity that developed the drug, which specified that the study \u201cwill evaluate the effect and safety\u201d of the immunogen.<\/p>\n","protected":false},"author":3134,"featured_media":246088,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[13902],"tags":[33386,34410],"ppma_author":[33546],"class_list":["post-246086","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cuba","tag-cuban-vaccine-against-covid-19","tag-mambisa"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cuba: clinical trial for booster dose with Mambisa vaccine candidate approved | OnCubaNews English<\/title>\n<meta name=\"description\" content=\"This was confirmed on the Twitter account of the Center for Genetic Engineering and Biotechnology (CIGB), the entity that developed the drug, which specified that the study \u201cwill evaluate the effect and safety\u201d of the immunogen.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/oncubanews.com\/en\/cuba\/cuba-clinical-trial-for-booster-dose-with-mambisa-vaccine-candidate-approved\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cuba: clinical trial for booster dose with Mambisa vaccine candidate approved | OnCubaNews English\" \/>\n<meta property=\"og:description\" content=\"This was confirmed on the Twitter account of the Center for Genetic Engineering and Biotechnology (CIGB), the entity that developed the drug, which specified that the study \u201cwill evaluate the effect and safety\u201d of the immunogen.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/oncubanews.com\/en\/cuba\/cuba-clinical-trial-for-booster-dose-with-mambisa-vaccine-candidate-approved\/\" \/>\n<meta property=\"og:site_name\" content=\"OnCubaNews English\" \/>\n<meta property=\"article:published_time\" content=\"2021-11-22T21:48:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2021\/11\/Vacuna-Mambisa-coronavirus-Cuba-1-750x508-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"750\" \/>\n\t<meta property=\"og:image:height\" content=\"508\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"OnCuba Staff\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"OnCuba Staff\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuba-clinical-trial-for-booster-dose-with-mambisa-vaccine-candidate-approved\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuba-clinical-trial-for-booster-dose-with-mambisa-vaccine-candidate-approved\\\/\"},\"author\":{\"name\":\"OnCuba Staff\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/#\\\/schema\\\/person\\\/d7171bf311032ab1f557dd8332e714af\"},\"headline\":\"Cuba: clinical trial for booster dose with Mambisa vaccine candidate approved\",\"datePublished\":\"2021-11-22T21:48:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuba-clinical-trial-for-booster-dose-with-mambisa-vaccine-candidate-approved\\\/\"},\"wordCount\":401,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuba-clinical-trial-for-booster-dose-with-mambisa-vaccine-candidate-approved\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/Vacuna-Mambisa-coronavirus-Cuba-1-750x508-1.jpg\",\"keywords\":[\"Cuban vaccine against COVID-19\",\"Mambisa\"],\"articleSection\":[\"Cuba\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuba-clinical-trial-for-booster-dose-with-mambisa-vaccine-candidate-approved\\\/#respond\"]}],\"copyrightYear\":\"2021\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuba-clinical-trial-for-booster-dose-with-mambisa-vaccine-candidate-approved\\\/\",\"url\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuba-clinical-trial-for-booster-dose-with-mambisa-vaccine-candidate-approved\\\/\",\"name\":\"Cuba: clinical trial for booster dose with Mambisa vaccine candidate approved | OnCubaNews English\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuba-clinical-trial-for-booster-dose-with-mambisa-vaccine-candidate-approved\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuba-clinical-trial-for-booster-dose-with-mambisa-vaccine-candidate-approved\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/Vacuna-Mambisa-coronavirus-Cuba-1-750x508-1.jpg\",\"datePublished\":\"2021-11-22T21:48:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/#\\\/schema\\\/person\\\/d7171bf311032ab1f557dd8332e714af\"},\"description\":\"This was confirmed on the Twitter account of the Center for Genetic Engineering and Biotechnology (CIGB), the entity that developed the drug, which specified that the study \u201cwill evaluate the effect and safety\u201d of the immunogen.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuba-clinical-trial-for-booster-dose-with-mambisa-vaccine-candidate-approved\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuba-clinical-trial-for-booster-dose-with-mambisa-vaccine-candidate-approved\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuba-clinical-trial-for-booster-dose-with-mambisa-vaccine-candidate-approved\\\/#primaryimage\",\"url\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/Vacuna-Mambisa-coronavirus-Cuba-1-750x508-1.jpg\",\"contentUrl\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/Vacuna-Mambisa-coronavirus-Cuba-1-750x508-1.jpg\",\"width\":750,\"height\":508},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/cuba\\\/cuba-clinical-trial-for-booster-dose-with-mambisa-vaccine-candidate-approved\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cuba: clinical trial for booster dose with Mambisa vaccine candidate approved\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/\",\"name\":\"OnCubaNews English\",\"description\":\"Revista sobre Cuba\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/#\\\/schema\\\/person\\\/d7171bf311032ab1f557dd8332e714af\",\"name\":\"OnCuba Staff\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4b4c4d6109baadde898bb1af22ea4a4af5f4417b86a5d1800bf17531bfb128fc?s=96&r=g17310096d4dde63ebae0e54fbb19218a\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4b4c4d6109baadde898bb1af22ea4a4af5f4417b86a5d1800bf17531bfb128fc?s=96&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4b4c4d6109baadde898bb1af22ea4a4af5f4417b86a5d1800bf17531bfb128fc?s=96&r=g\",\"caption\":\"OnCuba Staff\"},\"url\":\"https:\\\/\\\/oncubanews.com\\\/en\\\/author\\\/oncuba-editorial-staff\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cuba: clinical trial for booster dose with Mambisa vaccine candidate approved | OnCubaNews English","description":"This was confirmed on the Twitter account of the Center for Genetic Engineering and Biotechnology (CIGB), the entity that developed the drug, which specified that the study \u201cwill evaluate the effect and safety\u201d of the immunogen.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/oncubanews.com\/en\/cuba\/cuba-clinical-trial-for-booster-dose-with-mambisa-vaccine-candidate-approved\/","og_locale":"en_US","og_type":"article","og_title":"Cuba: clinical trial for booster dose with Mambisa vaccine candidate approved | OnCubaNews English","og_description":"This was confirmed on the Twitter account of the Center for Genetic Engineering and Biotechnology (CIGB), the entity that developed the drug, which specified that the study \u201cwill evaluate the effect and safety\u201d of the immunogen.","og_url":"https:\/\/oncubanews.com\/en\/cuba\/cuba-clinical-trial-for-booster-dose-with-mambisa-vaccine-candidate-approved\/","og_site_name":"OnCubaNews English","article_published_time":"2021-11-22T21:48:50+00:00","og_image":[{"width":750,"height":508,"url":"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2021\/11\/Vacuna-Mambisa-coronavirus-Cuba-1-750x508-1.jpg","type":"image\/jpeg"}],"author":"OnCuba Staff","twitter_card":"summary_large_image","twitter_misc":{"Written by":"OnCuba Staff","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/oncubanews.com\/en\/cuba\/cuba-clinical-trial-for-booster-dose-with-mambisa-vaccine-candidate-approved\/#article","isPartOf":{"@id":"https:\/\/oncubanews.com\/en\/cuba\/cuba-clinical-trial-for-booster-dose-with-mambisa-vaccine-candidate-approved\/"},"author":{"name":"OnCuba Staff","@id":"https:\/\/oncubanews.com\/en\/#\/schema\/person\/d7171bf311032ab1f557dd8332e714af"},"headline":"Cuba: clinical trial for booster dose with Mambisa vaccine candidate approved","datePublished":"2021-11-22T21:48:50+00:00","mainEntityOfPage":{"@id":"https:\/\/oncubanews.com\/en\/cuba\/cuba-clinical-trial-for-booster-dose-with-mambisa-vaccine-candidate-approved\/"},"wordCount":401,"commentCount":0,"image":{"@id":"https:\/\/oncubanews.com\/en\/cuba\/cuba-clinical-trial-for-booster-dose-with-mambisa-vaccine-candidate-approved\/#primaryimage"},"thumbnailUrl":"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2021\/11\/Vacuna-Mambisa-coronavirus-Cuba-1-750x508-1.jpg","keywords":["Cuban vaccine against COVID-19","Mambisa"],"articleSection":["Cuba"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/oncubanews.com\/en\/cuba\/cuba-clinical-trial-for-booster-dose-with-mambisa-vaccine-candidate-approved\/#respond"]}],"copyrightYear":"2021","copyrightHolder":{"@id":"https:\/\/oncubanews.com\/en\/#organization"}},{"@type":"WebPage","@id":"https:\/\/oncubanews.com\/en\/cuba\/cuba-clinical-trial-for-booster-dose-with-mambisa-vaccine-candidate-approved\/","url":"https:\/\/oncubanews.com\/en\/cuba\/cuba-clinical-trial-for-booster-dose-with-mambisa-vaccine-candidate-approved\/","name":"Cuba: clinical trial for booster dose with Mambisa vaccine candidate approved | OnCubaNews English","isPartOf":{"@id":"https:\/\/oncubanews.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/oncubanews.com\/en\/cuba\/cuba-clinical-trial-for-booster-dose-with-mambisa-vaccine-candidate-approved\/#primaryimage"},"image":{"@id":"https:\/\/oncubanews.com\/en\/cuba\/cuba-clinical-trial-for-booster-dose-with-mambisa-vaccine-candidate-approved\/#primaryimage"},"thumbnailUrl":"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2021\/11\/Vacuna-Mambisa-coronavirus-Cuba-1-750x508-1.jpg","datePublished":"2021-11-22T21:48:50+00:00","author":{"@id":"https:\/\/oncubanews.com\/en\/#\/schema\/person\/d7171bf311032ab1f557dd8332e714af"},"description":"This was confirmed on the Twitter account of the Center for Genetic Engineering and Biotechnology (CIGB), the entity that developed the drug, which specified that the study \u201cwill evaluate the effect and safety\u201d of the immunogen.","breadcrumb":{"@id":"https:\/\/oncubanews.com\/en\/cuba\/cuba-clinical-trial-for-booster-dose-with-mambisa-vaccine-candidate-approved\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/oncubanews.com\/en\/cuba\/cuba-clinical-trial-for-booster-dose-with-mambisa-vaccine-candidate-approved\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/oncubanews.com\/en\/cuba\/cuba-clinical-trial-for-booster-dose-with-mambisa-vaccine-candidate-approved\/#primaryimage","url":"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2021\/11\/Vacuna-Mambisa-coronavirus-Cuba-1-750x508-1.jpg","contentUrl":"https:\/\/oncubanews.com\/en\/wp-content\/uploads\/2021\/11\/Vacuna-Mambisa-coronavirus-Cuba-1-750x508-1.jpg","width":750,"height":508},{"@type":"BreadcrumbList","@id":"https:\/\/oncubanews.com\/en\/cuba\/cuba-clinical-trial-for-booster-dose-with-mambisa-vaccine-candidate-approved\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/oncubanews.com\/en\/"},{"@type":"ListItem","position":2,"name":"Cuba: clinical trial for booster dose with Mambisa vaccine candidate approved"}]},{"@type":"WebSite","@id":"https:\/\/oncubanews.com\/en\/#website","url":"https:\/\/oncubanews.com\/en\/","name":"OnCubaNews English","description":"Revista sobre Cuba","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/oncubanews.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/oncubanews.com\/en\/#\/schema\/person\/d7171bf311032ab1f557dd8332e714af","name":"OnCuba Staff","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/4b4c4d6109baadde898bb1af22ea4a4af5f4417b86a5d1800bf17531bfb128fc?s=96&r=g17310096d4dde63ebae0e54fbb19218a","url":"https:\/\/secure.gravatar.com\/avatar\/4b4c4d6109baadde898bb1af22ea4a4af5f4417b86a5d1800bf17531bfb128fc?s=96&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4b4c4d6109baadde898bb1af22ea4a4af5f4417b86a5d1800bf17531bfb128fc?s=96&r=g","caption":"OnCuba Staff"},"url":"https:\/\/oncubanews.com\/en\/author\/oncuba-editorial-staff\/"}]}},"authors":[{"term_id":33546,"user_id":3134,"is_guest":0,"slug":"oncuba-editorial-staff","display_name":"OnCuba Staff","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/4b4c4d6109baadde898bb1af22ea4a4af5f4417b86a5d1800bf17531bfb128fc?s=96&r=g","0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/posts\/246086","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/users\/3134"}],"replies":[{"embeddable":true,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/comments?post=246086"}],"version-history":[{"count":0,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/posts\/246086\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/media\/246088"}],"wp:attachment":[{"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/media?parent=246086"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/categories?post=246086"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/tags?post=246086"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/oncubanews.com\/en\/wp-json\/wp\/v2\/ppma_author?post=246086"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}